ELV logo

Elevance Health, Inc. (ELV) Cash From Financing

Annual CFF:

$1.19B+$4.54B(+135.62%)
December 31, 2024

Summary

  • As of today, ELV annual cash from financing is $1.19 billion, with the most recent change of +$4.54 billion (+135.62%) on December 31, 2024.
  • During the last 3 years, ELV annual cash from financing has risen by +$770.00 million (+182.03%).
  • ELV annual cash from financing is now -51.24% below its all-time high of $2.45 billion, reached on December 31, 2005.

Performance

ELV Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

Quarterly CFF:

$243.00M+$551.00M(+178.90%)
September 30, 2025

Summary

  • As of today, ELV quarterly cash from financing is $243.00 million, with the most recent change of +$551.00 million (+178.90%) on September 30, 2025.
  • Over the past year, ELV quarterly cash from financing has increased by +$1.16 billion (+126.56%).
  • ELV quarterly cash from financing is now -92.83% below its all-time high of $3.39 billion, reached on March 31, 2021.

Performance

ELV Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

TTM CFF:

-$566.00M+$1.16B(+67.17%)
September 30, 2025

Summary

  • As of today, ELV TTM cash from financing is -$566.00 million, with the most recent change of +$1.16 billion (+67.17%) on September 30, 2025.
  • Over the past year, ELV TTM cash from financing has increased by +$43.00 million (+7.06%).
  • ELV TTM cash from financing is now -121.14% below its all-time high of $2.68 billion, reached on March 31, 2013.

Performance

ELV TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ELV Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+135.6%+126.6%+7.1%
3Y3 Years+182.0%+119.4%+76.2%
5Y5 Years+152.7%+124.7%+62.4%

ELV Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+135.6%-82.7%+112.7%-147.4%+83.7%
5Y5-Yearat high+135.6%-92.8%+110.3%-147.4%+83.7%
All-TimeAll-Time-51.2%+131.9%-92.8%+110.3%-121.1%+89.4%

ELV Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$243.00M(+178.9%)
-$566.00M(+67.2%)
Jun 2025
-
-$308.00M(+83.9%)
-$1.72B(-130.5%)
Mar 2025
-
-$1.91B(-235.6%)
-$748.00M(-162.7%)
Dec 2024
$1.19B(+135.6%)
$1.41B(+253.9%)
$1.19B(+295.9%)
Sep 2024
-
-$915.00M(-237.0%)
-$609.00M(+11.5%)
Jun 2024
-
$668.00M(+1987.5%)
-$688.00M(+75.3%)
Mar 2024
-
$32.00M(+108.1%)
-$2.79B(+16.8%)
Dec 2023
-$3.35B(-154.1%)
-$394.00M(+60.4%)
-$3.35B(-4.2%)
Sep 2023
-
-$994.00M(+30.5%)
-$3.21B(+7.5%)
Jun 2023
-
-$1.43B(-169.3%)
-$3.47B(-60.0%)
Mar 2023
-
-$531.00M(-105.8%)
-$2.17B(-64.7%)
Dec 2022
-$1.32B(-411.6%)
-$258.00M(+79.4%)
-$1.32B(+44.5%)
Sep 2022
-
-$1.25B(-888.2%)
-$2.38B(-21.8%)
Jun 2022
-
-$127.00M(-139.4%)
-$1.95B(+26.2%)
Mar 2022
-
$322.00M(+124.5%)
-$2.64B(-724.8%)
Dec 2021
$423.00M(+116.5%)
-$1.31B(-58.4%)
$423.00M(+167.2%)
Sep 2021
-
-$830.00M(-1.2%)
-$629.00M(+19.7%)
Jun 2021
-
-$820.00M(-124.2%)
-$783.00M(-651.4%)
Mar 2021
-
$3.39B(+243.1%)
$142.00M(+105.5%)
Dec 2020
-$2.57B(-13.3%)
-$2.37B(-140.5%)
-$2.57B(-70.7%)
Sep 2020
-
-$984.00M(-1037.1%)
-$1.50B(-300.0%)
Jun 2020
-
$105.00M(-84.5%)
-$376.00M(+67.5%)
Mar 2020
-
$679.00M(+152.1%)
-$1.16B(+48.9%)
Dec 2019
-$2.27B(-1.1%)
-$1.30B(-1005.6%)
-$2.27B(+10.2%)
Sep 2019
-
$144.00M(+121.3%)
-$2.52B(+16.1%)
Jun 2019
-
-$677.00M(-57.8%)
-$3.01B(-47.3%)
Mar 2019
-
-$429.00M(+72.5%)
-$2.04B(+8.9%)
Dec 2018
-$2.24B(-624.9%)
-$1.56B(-358.3%)
-$2.24B(-227.8%)
Sep 2018
-
-$340.60M(-218.1%)
$1.75B(+320.4%)
Jun 2018
-
$288.30M(+145.9%)
$417.00M(+129.1%)
Mar 2018
-
-$627.70M(-125.8%)
-$1.44B(-436.2%)
Dec 2017
$426.90M(+158.2%)
$2.43B(+245.1%)
$426.90M(+130.0%)
Sep 2017
-
-$1.68B(-7.2%)
-$1.42B(-423.6%)
Jun 2017
-
-$1.56B(-226.7%)
-$272.10M(-131.8%)
Mar 2017
-
$1.23B(+112.3%)
$854.60M(+216.6%)
Dec 2016
-$732.90M(+75.5%)
$581.50M(+211.0%)
-$732.90M(+68.5%)
Sep 2016
-
-$524.10M(-19.9%)
-$2.33B(+2.9%)
Jun 2016
-
-$437.10M(-23.8%)
-$2.40B(+34.6%)
Mar 2016
-
-$353.20M(+65.1%)
-$3.66B(-22.2%)
Dec 2015
-$3.00B(-64.5%)
-$1.01B(-70.5%)
-$3.00B(-19.2%)
Sep 2015
-
-$593.90M(+65.1%)
-$2.51B(-1.3%)
Jun 2015
-
-$1.70B(-646.0%)
-$2.48B(-98.2%)
Mar 2015
-
$311.90M(+159.0%)
-$1.25B(+31.3%)
Dec 2014
-$1.82B(-6.1%)
-$528.90M(+5.7%)
-$1.82B(+9.8%)
Sep 2014
-
-$560.90M(-18.3%)
-$2.02B(-1.2%)
Jun 2014
-
-$474.10M(-83.3%)
-$2.00B(-42.8%)
Mar 2014
-
-$258.60M(+64.4%)
-$1.40B(+18.7%)
Dec 2013
-$1.72B(-182.2%)
-$725.80M(-35.2%)
-$1.72B(-286.7%)
Sep 2013
-
-$536.80M(-533.3%)
-$444.20M(-126.8%)
Jun 2013
-
$123.90M(+121.4%)
$1.66B(-38.0%)
Mar 2013
-
-$579.10M(-205.7%)
$2.68B(+28.1%)
DateAnnualQuarterlyTTM
Dec 2012
$2.09B(+203.5%)
$547.80M(-65.0%)
$2.09B(+162.1%)
Sep 2012
-
$1.57B(+37.2%)
$797.10M(+249.0%)
Jun 2012
-
$1.14B(+197.8%)
-$535.10M(+77.7%)
Mar 2012
-
-$1.17B(-56.9%)
-$2.40B(-18.9%)
Dec 2011
-$2.02B(+36.3%)
-$744.00M(-417.8%)
-$2.02B(+8.8%)
Sep 2011
-
$234.10M(+132.4%)
-$2.21B(+2.9%)
Jun 2011
-
-$723.50M(+7.9%)
-$2.28B(+18.4%)
Mar 2011
-
-$785.80M(+16.4%)
-$2.80B(+11.7%)
Dec 2010
-$3.17B(+6.9%)
-$939.80M(-661.1%)
-$3.17B(+7.9%)
Sep 2010
-
$167.50M(+113.5%)
-$3.44B(+27.3%)
Jun 2010
-
-$1.24B(-7.0%)
-$4.73B(-8.6%)
Mar 2010
-
-$1.16B(+4.3%)
-$4.35B(-27.9%)
Dec 2009
-$3.40B(+8.9%)
-$1.21B(-7.9%)
-$3.40B(-16.2%)
Sep 2009
-
-$1.12B(-29.7%)
-$2.93B(-8.1%)
Jun 2009
-
-$864.30M(-317.7%)
-$2.71B(-21.3%)
Mar 2009
-
-$206.90M(+71.9%)
-$2.24B(+40.2%)
Dec 2008
-$3.74B(-9.6%)
-$736.70M(+18.4%)
-$3.74B(+16.6%)
Sep 2008
-
-$902.50M(-131.9%)
-$4.48B(+15.9%)
Jun 2008
-
-$389.20M(+77.2%)
-$5.32B(-15.8%)
Mar 2008
-
-$1.71B(-15.3%)
-$4.60B(-34.8%)
Dec 2007
-$3.41B(+8.5%)
-$1.48B(+15.3%)
-$3.41B(-26.6%)
Sep 2007
-
-$1.75B(-617.9%)
-$2.69B(-247.1%)
Jun 2007
-
$337.60M(+165.0%)
-$775.70M(+68.5%)
Mar 2007
-
-$519.00M(+32.0%)
-$2.46B(+34.0%)
Dec 2006
-$3.73B(-252.3%)
-$762.70M(-552.9%)
-$3.73B(-596.8%)
Sep 2006
-
$168.40M(+112.5%)
-$534.60M(+36.1%)
Jun 2006
-
-$1.35B(+24.6%)
-$836.10M(-271.5%)
Mar 2006
-
-$1.79B(-173.5%)
$487.60M(-80.1%)
Dec 2005
$2.45B(+18.6%)
$2.43B(+1924.0%)
$2.45B(+16.4%)
Sep 2005
-
-$133.10M(-507.8%)
$2.10B(-3.3%)
Jun 2005
-
-$21.90M(-112.6%)
$2.17B(-1.6%)
Mar 2005
-
$173.80M(-91.7%)
$2.21B(+7.0%)
Dec 2004
$2.06B(+893.0%)
$2.08B(+3453.9%)
$2.06B(+2915.0%)
Sep 2004
-
-$62.10M(-596.8%)
-$73.30M(+48.1%)
Jun 2004
-
$12.50M(-58.6%)
-$141.20M(+6.9%)
Mar 2004
-
$30.20M(+156.0%)
-$151.60M(+41.7%)
Dec 2003
-$260.20M(-136.7%)
-$53.90M(+58.5%)
-$260.20M(+23.4%)
Sep 2003
-
-$130.00M(-6290.5%)
-$339.50M(-150.6%)
Jun 2003
-
$2.10M(+102.7%)
$670.30M(+6.3%)
Mar 2003
-
-$78.40M(+41.1%)
$630.80M(-11.1%)
Dec 2002
$709.30M(+1422.1%)
-$133.20M(-115.1%)
$709.30M(-20.2%)
Sep 2002
-
$879.80M(+2452.4%)
$889.10M(+9460.2%)
Jun 2002
-
-$37.40M(>-9900.0%)
$9.30M(-80.1%)
Mar 2002
-
$100.00K(-99.8%)
$46.70M(+0.2%)
Dec 2001
$46.60M(-38.3%)
$46.60M(>+9900.0%)
$46.60M(>+9900.0%)
Sep 2001
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2001
-
$0.00
$0.00
Dec 2000
$75.50M(-65.7%)
-
-
Dec 1999
$220.10M(+5892.1%)
-
-
Dec 1998
-$3.80M
-
-

FAQ

  • What is Elevance Health, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Elevance Health, Inc.?
  • What is Elevance Health, Inc. annual cash from financing year-on-year change?
  • What is Elevance Health, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Elevance Health, Inc.?
  • What is Elevance Health, Inc. quarterly cash from financing year-on-year change?
  • What is Elevance Health, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Elevance Health, Inc.?
  • What is Elevance Health, Inc. TTM cash from financing year-on-year change?

What is Elevance Health, Inc. annual cash from financing?

The current annual cash from financing of ELV is $1.19B

What is the all-time high annual cash from financing for Elevance Health, Inc.?

Elevance Health, Inc. all-time high annual cash from financing is $2.45B

What is Elevance Health, Inc. annual cash from financing year-on-year change?

Over the past year, ELV annual cash from financing has changed by +$4.54B (+135.62%)

What is Elevance Health, Inc. quarterly cash from financing?

The current quarterly cash from financing of ELV is $243.00M

What is the all-time high quarterly cash from financing for Elevance Health, Inc.?

Elevance Health, Inc. all-time high quarterly cash from financing is $3.39B

What is Elevance Health, Inc. quarterly cash from financing year-on-year change?

Over the past year, ELV quarterly cash from financing has changed by +$1.16B (+126.56%)

What is Elevance Health, Inc. TTM cash from financing?

The current TTM cash from financing of ELV is -$566.00M

What is the all-time high TTM cash from financing for Elevance Health, Inc.?

Elevance Health, Inc. all-time high TTM cash from financing is $2.68B

What is Elevance Health, Inc. TTM cash from financing year-on-year change?

Over the past year, ELV TTM cash from financing has changed by +$43.00M (+7.06%)
On this page